SO
INO icon

STRS Ohio’s Inovio Pharmaceuticals INO Stock Holding History

STRS Ohio’s Portfolio INO Stock Details INO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-325
Closed -$45K – 2216
2020
Q3 		$45K Sell
325
-992
-75% -$207K ﹤0.01% 1989
2020
Q2 		$425K Buy
+1,317
New +$211K ﹤0.01% 1409
2016
Q4 		– Sell
-1,317
Closed -$147K – 1959
2016
Q3 		$147K Sell
1,317
-50
-4% -$5.52K ﹤0.01% 1604
2016
Q2 		$151K Buy
+1,367
New +$166K ﹤0.01% 1622

Other funds holding INO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

STRS Ohio's INO Position: Q4 2020 in Review

STRS Ohio sold out of Inovio Pharmaceuticals (INO) in Q4 2020, closing a stake of 325 shares — an estimated $45K sold.

STRS Ohio first reported a position in INO in Q2 2016 and held it in 4 quarters. The position peaked at $425K in Q2 2020. 227 funds tracked by Wall St. Rank hold INO as of Q4 2020.

  • STRS Ohio reported no remaining Inovio Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
  • STRS Ohio sold 325 Inovio Pharmaceuticals shares in Q4 2020, an estimated $45K.
  • STRS Ohio first reported a position in Inovio Pharmaceuticals in Q2 2016 and held it in 4 quarters.
  • STRS Ohio's Inovio Pharmaceuticals position peaked at $425K in Q2 2020.
  • 227 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q4 2020.

Based on STRS Ohio's 13F filing for Q4 2020, filed 25 Jan 2021.